These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7164470)

  • 1. [Important side effects of non-steroidal antirheumatic agents].
    Kolarz G
    Wien Med Wochenschr; 1982 Dec; 132(23-24):592-5. PubMed ID: 7164470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antirheumatic therapy with new non-steroidal compounds (author's transl)].
    Fenner H
    MMW Munch Med Wochenschr; 1981 Sep; 123(37):1377-82. PubMed ID: 6793854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interaction problems in the therapy with steroid-free anti-rheumatics].
    Husmann F
    Fortschr Med; 1981 Aug; 99(31-32):1231-5. PubMed ID: 7274937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary effects of non-steroid anti-inflammatory agents on kidney function].
    de Torrenté A
    Schweiz Med Wochenschr; 1983 Jul; 113(29):1019-22. PubMed ID: 6612281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination of low molecular weight heparin and non-steroidal anti-inflammatory agents].
    Dahl V; Raeder J
    Tidsskr Nor Laegeforen; 1995 May; 115(14):1728-30. PubMed ID: 7785032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastric protection against non-steroidal and steroidal antiinflammatory agents in internal medicine specialties: survey on prescription trends among hospital internal medicine physicians (Gardenia Project)].
    Scarpato S; Acampora R; Corsaro S; De Riso L; De Silva S; La Palombara F; Lupoli S; Russo R
    Ann Ital Med Int; 2002; 17(1):41-6. PubMed ID: 11975113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interesting practical facts on the pharmacology of non-steroidal antirheumatic agents].
    Fenner H
    Wien Med Wochenschr; 1982 Dec; 132(23-24):586-8. PubMed ID: 6819722
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic aspects of non-steroidal anti-inflammatory drug gastropathy.
    Walan A; Wahlqvist P
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S79-88. PubMed ID: 10379474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical immunotoxicity of antirheumatic drugs.
    Bálint G; Gergely P
    Inflamm Res; 1996 Dec; 45 Suppl 2():S91-5. PubMed ID: 8988409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antirheumatic agents: CNS toxicity and its avoidance.
    Iobst WF; Bridges CR; Regan-Smith MG
    Geriatrics; 1989 Apr; 44(4):95, 99-100, 102. PubMed ID: 2647590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects of the clinical pharmacology of non-steroidal anti-inflammatory drugs.
    Graham GG; Day RO; Champion GD; Lee E; Newton K
    Clin Rheum Dis; 1984 Aug; 10(2):229-49. PubMed ID: 6439458
    [No Abstract]   [Full Text] [Related]  

  • 14. The use and safety profile of non-steroidal antiinflammatory drugs among Turkish patients with osteoarthritis.
    Yilmaz H; Gürel S; Ozdemir O
    Turk J Gastroenterol; 2005 Sep; 16(3):138-42. PubMed ID: 16245223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-steroid antirheumatic agents. Criteria for a rational selection].
    Rechziegler H
    Fortschr Med; 1984 May; 102(17):497-502. PubMed ID: 6735323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turkish patients with osteoarthritis: their awareness of the side effects of NSAIDs.
    Yilmaz H; Gürel S; Ozdemir O
    Turk J Gastroenterol; 2005 Jun; 16(2):89-92. PubMed ID: 16252199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
    Dammann HG
    Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastrointestinal lesions produced by nonsteroidal anti-inflammatory agents: the clinical manifestations, risk factors, physiopathology, prevention and treatment].
    Martín de Argila C; Moreira V; Gisbert JP
    An Med Interna; 1995 Feb; 12(2):85-96. PubMed ID: 7749017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-steroidal antirheumatic agents - questions of the clinician to the pharmacologist].
    Mathies H
    Fortschr Med; 1982 Sep; 100(36):1635-40. PubMed ID: 6982841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forthcoming non-steroidal anti-inflammatory drugs: are they really devoid of side effects?
    Bjarnason I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S27-36. PubMed ID: 10379467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.